Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
IVI opens Country Office in Austria 2023-01-25 11:17
DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease 2023-01-25 08:35
Complete Genomics to Announce New Product Launches at AGBT General Meeting 2023-01-24 20:30
CARsgen Presents Results on Anti-Claudin18.2-mAb AB011 at ASCO GI 2023-01-20 21:50
SK bioscience Appoints New Executives to Accelerate New Growth Strategies 2023-01-20 20:00
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Advanced, Recurrent or Metastatic Endometrial Carcinoma with HER2 Overexpression 2023-01-20 18:00
BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS 2023-01-20 13:10
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases 2023-01-20 09:50
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS 2023-01-20 02:00
Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date 2023-01-19 23:10
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata 2023-01-19 23:05
Hepagene Therapeutics Reports Positive Top-line Results for Phase 2a RISE Study of FXR Agonist HPG1860 in Patients with NASH 2023-01-19 23:00
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA 2023-01-19 18:56
Tigermed Completes Acquisition of Marti Farm 2023-01-19 14:59
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List 2023-01-19 11:45
Innovent Announces Inclusion in the China National Reimbursement Drug List (NRDL) of TYVYT in Two New Indications, Olverembatinib for the First Listing, BYVASDA, HALPRYZA and SULINNO in Multiple New Indications 2023-01-18 21:34
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster 2023-01-18 21:00
Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services 2023-01-18 19:00
Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS 2023-01-18 18:03
WFH Gene Therapy Registry: now live! 2023-01-18 18:00
1 129 130 131 132 133 452